Paradromics Stock
HealthTechLooking to sell Paradromics stock or options?
Paradromics develops data-rate brain-computer interface technology aimed at enhancing data transmission rates between the human brain and machines. This technology provides high-volume, bidirectional data streaming between brains and computers, allowing patients with neurological disorders to overcome deficits in biological connectivity.
Capital Factory, Julien Nguyen, Wescott Capital, Deepwater Asset Management, Pureland Group, Dolby Family Ventures, Arjun Bansal, 2050 Capital, Stelac Capital Partners, FJ Labs, Primavera Venture Partners, What If Ventures, Wealthing VC Club, Prime Movers Lab, ATEL Capital Group, Westcott, 15th Rock, Wormhole Capital, Kaitai Capital, Bluebirds Capital, Cloudstone Capital, Explorer Equity Group, Synergy Ventures, Jun Deng, Harmonix Fund.